213 related articles for article (PubMed ID: 26826330)
1. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
[TBL] [Abstract][Full Text] [Related]
2. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
3. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
[TBL] [Abstract][Full Text] [Related]
4. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.
McLaughlin JP; Land BB; Li S; Pintar JE; Chavkin C
Neuropsychopharmacology; 2006 Apr; 31(4):787-94. PubMed ID: 16123754
[TBL] [Abstract][Full Text] [Related]
5. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
[TBL] [Abstract][Full Text] [Related]
6. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
[TBL] [Abstract][Full Text] [Related]
7. Differential Roles of Accumbal GSK3
Shi X; Barr JL; von Weltin E; Wolsh C; Unterwald EM
J Pharmacol Exp Ther; 2019 Nov; 371(2):339-347. PubMed ID: 31420527
[TBL] [Abstract][Full Text] [Related]
8. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
[TBL] [Abstract][Full Text] [Related]
9. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
Bruchas MR; Macey TA; Lowe JD; Chavkin C
J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
[TBL] [Abstract][Full Text] [Related]
10. Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse.
Huge V; Rammes G; Beyer A; Zieglgänsberger W; Azad SC
Eur J Pain; 2009 Feb; 13(2):124-9. PubMed ID: 18439862
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
[TBL] [Abstract][Full Text] [Related]
13. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
[TBL] [Abstract][Full Text] [Related]
14. κ Opioid receptor activation in different brain regions differentially modulates anxiety-related behaviors in mice.
Wang YJ; Hang A; Lu YC; Long Y; Zan GY; Li XP; Wang Q; Zhao ZX; He L; Chi ZQ; Liu JG
Neuropharmacology; 2016 Nov; 110(Pt A):92-101. PubMed ID: 27106167
[TBL] [Abstract][Full Text] [Related]
15. Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.
Robles CF; McMackin MZ; Campi KL; Doig IE; Takahashi EY; Pride MC; Trainor BC
Behav Brain Res; 2014 Apr; 262():84-93. PubMed ID: 24445073
[TBL] [Abstract][Full Text] [Related]
16. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
19. Activation of extracellular signal-regulated kinase is critical for the discriminative stimulus effects induced by U-50,488H.
Yoshizawa K; Narita M; Saeki M; Narita M; Isotani K; Horiuchi H; Imai S; Kuzumaki N; Suzuki T
Synapse; 2011 Oct; 65(10):1052-61. PubMed ID: 21465566
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
